Economic evaluation of high-dose (80 mg/day) atorvastatin treatment compared with standard-dose (20 mg/day to 40 mg/day) simvastatin treatment in Canada based on the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) trial

✍ Scribed by Monika Wagner; Peter Lindgren; Elizabeth Merikle; Mireille Goetghebeur; Bengt Jönsson

• Book ID: 117579966
• Publisher: Pulsus Group Inc
• Year: 2009
• Tongue: English
• Weight: 856 KB
• Volume: 25
• Category: Article
• ISSN: 0828-282X
• DOI: 10.1016/s0828-282x(09)70159-x